Biologic Breakthroughs for Severe Asthma with Dr. Mario Castro

Lungcast

Content provided by American Lung Association. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by American Lung Association or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

3y ago 45:52

MP3•Episode home

Dr. Castro and Dr. Rizzo discuss the evolving world of monoclonal antibodies for the treatment of severe asthma. Plus, the ALA team discusses September's annual Asthma Peak Week, and what it means for reopening schools.
See and read more Lungcast recaps and additional interviews at HCPLive.com/sap-partner/american-lung-association.
Listen to Dr. Rizzo's interview with Dr. Anne Dixon on the 2020 asthma management guidelines here.
Visit Lung.org for more resources and expert insights into respiratory disease management.

Episode highlights

0:15 Back to school with Asthma Peak Week
9:48 Biologics: the emerging severe asthma treatment field
11:34 Defining type 2 inflammation and severe asthma
15:47 Severe asthma biomarkers
21:23 IL-4, IL-13, TSLP: Promising pathways
25:49 Severe asthma diagnostic clues
28:34 Asthma biologic decision-making
35:31 How long-term is a biologic therapy?
37:44 The future of asthma-modifying therapy
41:09 Understanding asthmatic COVID-19 risk
44:57 Outro

52 episodes

#Science #Fitness #News Talk #Medicine #News #American Lung Association